X0508 4 2023-12-06 0 0001400810 HCI Group, Inc. HCI 0001439934 Patel Paresh 3802 COCONUT PALM DRIVE TAMPA FL 33619 1 1 1 0 Chief Executive Officer 0 Common Stock 2023-12-06 4 J 0 5000 78.00 A 338000 D Common stock 37500 I IRA Common stock 447000 D Common Stock 10000 D Common Stock 10000 D Stock Option (Right to Buy) 40.00 2027-01-07 Common 110000 110000 D Stock Option (Right to Buy) 40.00 2028-02-08 Common 110000 110000 D Stock Option (Right to Buy) 53.00 2029-01-15 Common 110000 110000 D Stock Option (Right to Buy) 48.00 2030-01-16 Common 110000 110000 D Stock Option (Right to Buy) 70.00 2033-09-15 Common 150000 150000 D The Reporting Person purchased 5,000 common shares for $78 per share in a secondary offering. The offering was part of an underwriten public offering of HCI Group, Inc. common shares. Shares held jointly with spouse. Restricted stock grant of 40,000 shares effective January 16, 2020: Restrictions on 10,000 shares will lapse on each of January 16, 2021, January 16, 2022, January 16, 2023, and January 16, 2024. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 16, 2020. Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021. The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan. The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. All options have vested and may be exercised at any time up to and including January 7, 2027. The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. All options have vested and may be exercised at any time up to and including February 8, 2028. The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. All options have vested and may be exercised at any time up to and including January 15, 2029. The options were granted on January 16, 2020 at an exercise price of $48.00 per share, in excess of the $45.97 market value. Of the 110,000 options, 82,500 have vested and the remaining 27,500 options will vest January 16, 2024. Once vested, the options may be exercised at any time up to and including January 16, 2030. The options were granted on September 15, 2023 and the options will vest, if ever, on the date on which the company stock value first equals or exceeds $80.00 for 20 consecutive trading days on the applicable exchange. If the above conditions are met, the options will be exercisable at an exercise price of $70.00 per share. The options will expire on September 15, 2033. /s/ Andrew L. Graham as Attorney-in-fact for Paresh Patel 2023-12-08